BOKF vs GSK · P/E 13, rev $1.26B vs P/E 13, $103.31B cap
BOK Financial Corporation (BOKF) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
BOK Financial Corporation (BOKF) is a banks - regional company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BOKF revenue for 2026-06-30 was $1.26B. Net income was $332.3M. BOKF currently screens at market cap $7.85B and trailing P/E 13.1.
GSK does not have a complete income-statement cache yet.
BOKF currently screens at market cap $7.85B and trailing P/E 13.1. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BOKF and GSK stock pages for the full models.
Not investment advice.